Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis

Primary Epiphyseal Arteriopathy in a Mouse Model of Steroid-Induced Osteonecrosis

(2013) Laura J. Janke et al.   AMERICAN JOURNAL OF PATHOLOGY

Osteonecrosis development in a novel rat model characterized by a single application of oxidative stress

(2011) Toru Ichiseki et al.   ARTHRITIS AND RHEUMATISM

Cellular and Molecular Mechanisms of Bone Remodeling

(2010) Liza J. Raggatt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Increased fat due to estrogen deficiency induces bone loss by elevating monocyte chemoattractant protein-1 (MCP-1) production

(2010) Youn-Young Kim et al.   MOLECULES AND CELLS

Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model

(2009) K Takashima et al.   BRITISH JOURNAL OF PHARMACOLOGY

Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway

(2009) S. Okazaki et al.   RHEUMATOLOGY

Taking a Toll on the bones: Regulation of bone metabolism by innate immune regulators

(2008) Zvi Bar-Shavit   AUTOIMMUNITY

TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain

(2008) Tomohiro Kawamoto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY